• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Letter to the editor on "Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis".致编辑的信：关于“减重干预改善肥胖患者代谢功能障碍相关脂肪性肝炎：一项系统评价与荟萃分析”
Clin Mol Hepatol. 2025 Jan;31(1):e15-e16. doi: 10.3350/cmh.2024.0784. Epub 2024 Sep 12.
2
Correspondence to letter to the editor on "Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis".致编辑的信，内容涉及“减肥干预改善肥胖患者代谢功能障碍相关脂肪性肝炎：一项系统评价与荟萃分析”
Clin Mol Hepatol. 2025 Jan;31(1):e103-e104. doi: 10.3350/cmh.2024.0818. Epub 2024 Sep 24.
3
Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis.减重干预可改善肥胖患者代谢功能障碍相关脂肪性肝炎：系统评价和荟萃分析。
Clin Mol Hepatol. 2024 Jul;30(3):561-576. doi: 10.3350/cmh.2023.0384. Epub 2024 Jun 3.
4
Bariatric Surgery and Metabolic Dysfunction-Associated Fatty Liver Disease: a 2022 Update.减重手术与代谢相关脂肪性肝病：2022 年更新。
Praxis (Bern 1994). 2023 Feb;112(2):97-102. doi: 10.1024/1661-8157/a003969.
5
Bariatric surgery improves nonalcoholic fatty liver disease: a contemporary systematic review and meta-analysis.减重手术改善非酒精性脂肪性肝病：当代系统评价和荟萃分析。
Surg Obes Relat Dis. 2019 Mar;15(3):502-511. doi: 10.1016/j.soard.2018.12.002. Epub 2018 Dec 6.
6
Long-term Results of Bariatric Surgery for Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis Treatment in Morbidly Obese Japanese Patients.日本病态肥胖患者接受减重手术治疗非酒精性脂肪性肝病/非酒精性脂肪性肝炎的长期疗效。
Obes Surg. 2019 Apr;29(4):1195-1201. doi: 10.1007/s11695-018-03641-2.
7
Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects.非酒精性脂肪性肝病患者的减肥手术——从病理生理学到临床效果
World J Hepatol. 2019 Feb 27;11(2):138-149. doi: 10.4254/wjh.v11.i2.138.
8
[Prevalence and associated factors to non-alcoholic steatohepatitis in obese patients subjected to bariatric surgery].[接受减肥手术的肥胖患者中非酒精性脂肪性肝炎的患病率及相关因素]
Cir Esp. 2008 Dec;84(6):313-7. doi: 10.1016/s0009-739x(08)75041-3.
9
Prevalence of Non-alcoholic Fatty Liver Disease and Steatohepatitis Risk Factors in Patients Undergoing Bariatric Surgery.接受减肥手术患者的非酒精性脂肪性肝病患病率及脂肪性肝炎危险因素
Obes Surg. 2015 Dec;25(12):2335-43. doi: 10.1007/s11695-015-1696-5.
10
Bariatric surgery and non-alcoholic fatty liver disease.减重手术与非酒精性脂肪性肝病。
Med Clin (Barc). 2022 Jun 10;158(11):550-555. doi: 10.1016/j.medcli.2021.12.003. Epub 2022 Feb 2.

引用本文的文献

1
Correspondence to letter to the editor on "Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis".致编辑的信，内容涉及“减肥干预改善肥胖患者代谢功能障碍相关脂肪性肝炎：一项系统评价与荟萃分析”
Clin Mol Hepatol. 2025 Jan;31(1):e103-e104. doi: 10.3350/cmh.2024.0818. Epub 2024 Sep 24.

本文引用的文献

1
Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis.减重干预可改善肥胖患者代谢功能障碍相关脂肪性肝炎：系统评价和荟萃分析。
Clin Mol Hepatol. 2024 Jul;30(3):561-576. doi: 10.3350/cmh.2023.0384. Epub 2024 Jun 3.
2
Evaluation of Health-Related Quality of Life in Adolescents With Obesity: A Randomized Qualitative Study Among Healthcare Professionals.肥胖青少年健康相关生活质量评估：医疗保健专业人员的一项随机定性研究。
Cureus. 2024 Jan 9;16(1):e51928. doi: 10.7759/cureus.51928. eCollection 2024 Jan.
3
Global incidence of adverse clinical events in non-alcoholic fatty liver disease: A systematic review and meta-analysis.全球非酒精性脂肪性肝病不良临床事件发生率：系统评价和荟萃分析。
Clin Mol Hepatol. 2024 Apr;30(2):235-246. doi: 10.3350/cmh.2023.0485. Epub 2024 Jan 26.
4
Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association.非酒精性脂肪性肝病与心血管风险：美国心脏协会的科学声明
Arterioscler Thromb Vasc Biol. 2022 Jun;42(6):e168-e185. doi: 10.1161/ATV.0000000000000153. Epub 2022 Apr 14.
5
Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease.生活方式干预对非肥胖非酒精性脂肪性肝病患者的有益影响。
J Hepatol. 2018 Dec;69(6):1349-1356. doi: 10.1016/j.jhep.2018.08.011. Epub 2018 Aug 22.
6
Weight trajectories through infancy and childhood and risk of non-alcoholic fatty liver disease in adolescence: the ALSPAC study.婴幼儿期及儿童期体重轨迹与青少年非酒精性脂肪性肝病风险：阿冯纵向父母与儿童研究（ALSPAC）
J Hepatol. 2014 Sep;61(3):626-32. doi: 10.1016/j.jhep.2014.04.018. Epub 2014 Apr 24.

Letter to the editor on "Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis".

作者信息

Li Xiao-Song, Shen Xi-Ping, Li Hang

机构信息

Department of General Surgery, Suzhou Ninth Hospital Affiliated to Soochow University, Suzhou, China.

出版信息

Clin Mol Hepatol. 2025 Jan;31(1):e15-e16. doi: 10.3350/cmh.2024.0784. Epub 2024 Sep 12.

DOI:10.3350/cmh.2024.0784
PMID:39262291
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11791553/
Abstract
摘要